This content is restricted to members.
To view our premium content, sign up for a membership:
« Back to Research Deepdives
‹ Back to Research Deepdives
Does ‘Synbiotic’ Supplementation Improve PCOS Symptoms?
References
1. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility. 2004;81(1):19-25.
2. Pasquali R, Gambineri A. Glucose intolerance states in women with the polycystic ovary syndrome. Journal of Endocrinological Investigation. 2013;36(8):648-653.
3. Hill C, Guarner F, Reid G, Gibson G, Merenstein D, Pot B et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology. 2014;11(8):506-514.
4. Gibson G, Hutkins R, Sanders M, Prescott S, Reimer R, Salminen S et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nature Reviews Gastroenterology & Hepatology. 2017;14(8):491-502.
5. Swanson K, Gibson G, Hutkins R, Reimer R, Reid G, Verbeke K et al. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nature Reviews Gastroenterology & Hepatology. 2020;17(11):687-701.
6. Askari G, Shoaei T, Tehrani H, Heidari-Beni M, feizi A, Esmaillzadeh A. Effects of probiotic supplementation on pancreatic β-cell function and c-reactive protein in women with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial. International Journal of Preventive Medicine. 2015;6(1):27.
7. Kolida S, Tuohy K, Gibson G. Prebiotic effects of inulin and oligofructose. British Journal of Nutrition. 2002;87(6):193-197.
8. Qu X, Donnelly R. Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome. International Journal of Molecular Sciences. 2020;21(21):8191.
9. Kajaia N, Binder H, Dittrich R, Oppelt P, Flor B, Cupisti S et al. Low sex hormone-binding globulin as a predictive marker for insulin resistance in women with hyperandrogenic syndrome. European Journal of Endocrinology. 2007;157(4):499-507.
10. Sirmans S, Pate K. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clinical Epidemiology. 2013;:1.
11. Sprung V, Atkinson G, Cuthbertson D, Pugh C, Aziz N, Green D et al. Endothelial function measured using flow-mediated dilation in polycystic ovary syndrome: a meta-analysis of the observational studies. Clinical Endocrinology. 2013;78(3):438-446.
12. Chudzicka-Strugała I, Kubiak A, Banaszewska B, Zwozdziak B, Siakowska M, Pawelczyk L et al. Effects of synbiotic supplementation and lifestyle modifications on women with polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism. 2021;.
13. Mehrabani H, Salehpour S, Amiri Z, Farahani S, Meyer B, Tahbaz F. Beneficial Effects of a High-Protein, Low-Glycemic-Load Hypocaloric Diet in Overweight and Obese Women with Polycystic Ovary Syndrome: A Randomized Controlled Intervention Study. Journal of the American College of Nutrition. 2012;31(2):117-125.
14. Gower B, Chandler-Laney P, Ovalle F, Goree L, Azziz R, Desmond R et al. Favourable metabolic effects of a eucaloric lower-carbohydrate diet in women with PCOS. Clinical Endocrinology. 2013;79(4):550-557.
15. Goss A, Chandler-Laney P, Ovalle F, Goree L, Azziz R, Desmond R et al. Effects of a eucaloric reduced-carbohydrate diet on body composition and fat distribution in women with PCOS. Metabolism. 2014;63(10):1257-1264.
16. Unfer V, Porcaro G. Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome. Expert Review of Clinical Pharmacology. 2014;7(5):623-631.